Please assess the completion status of the following clinical trial:

Trial Title: IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Meets criteria for clinically significant symptoms of depression or anxiety using self-report measures used in screening for depression, as well as interviewer administered measures to ensure symptoms are not transitory and have been present for at least two weeks.~* Is familiar with the use of mobile phones~* Has an Android phone and is willing download the IntelliCare apps on their own device~* Is able to speak and read English~* Is at least 19 years of age~* Is able to give informed consent~Exclusion Criteria:~* Has visual, hearing, voice, or motor impairment that would prevent completion of study and treatment procedures~* Has any psychiatric condition for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous (e.g., psychotic disorders, bipolar disorders, dissociative disorders, obsessive compulsive disorder, severe post traumatic stress disorder, etc.).~* Exhibits severe suicidality, including ideation, plan, and intent.~* Currently receiving psychotherapy or planning to receive psychotherapy during the 8 weeks of the study.~* Participants who have been on an antidepressant or anxiolytic medication with no dose changes for 2 weeks and do not intend to change the dose will be eligible. Those who have been on the antidepressant or anxiolytic for less than 2 weeks or intend to have their medication optimized will be asked to wait for screening until they meet the 2-week criterion.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 8-Week Single Arm Field Trial (Type: EXPERIMENTAL): Use of IntelliCare program for 8 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).